Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Gothenburg
Clinical trial register · Sweden

Clinical Trials in Gothenburg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2219 matching records held by the registry are in this view. Synced 12 Oct 2026, 03:19 UTC
2219
Studies in scope
all four open statuses
1247
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 28 Uppsala 18 Gothenburg 16 Lund 10 Linköping 5
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm28 Uppsala18 Gothenburg16 Lund10 Linköping5
All 14 locations
Target enrolment
to

Trials with a site in Gothenburg

16 of 2219 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
134
Gothenburg
2026-07-06
Recruiting
Merck Sharp & Dohme LLC
Phase 2
150
Stockholm, Gothenburg
2025-12-04
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
50
Gothenburg
2025-05-26
Active, closed
Merck Sharp & Dohme LLC
Phase 2
440
Gothenburg
2025-04-16
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
NCT06395103B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma, Neuroblastoma
Merck Sharp & Dohme LLC
Phase 1/2
90
Gothenburg
2024-08-16
Active, closed
Merck Sharp & Dohme LLC
Phase 3
300
Lund, Huddinge, Uppsala, Gothenburg, Örebro
2024-07-16
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Gävle, Stockholm, Uppsala, Borås, Gothenburg
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Stockholm, Uppsala, Gothenburg
2023-12-31
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Lund, Gothenburg
2023-07-19
Active, closed
A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)
NCT05458297Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma, Richter Transformation Lymphoma
Merck Sharp & Dohme LLC
Phase 2
189
Lund, Uppsala, Gothenburg
2022-07-21
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Lund, Stockholm, Uppsala, Gothenburg
2021-08-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
815
Gothenburg
2021-05-12
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-sweden/city/gothenburg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,219 studies in total at the last sync on 12 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 16 of those studies with a site in Gothenburg that also match the filters currently applied.

How many clinical trials are recruiting in Gothenburg?

8 of the 16 studies on this page are recruiting new participants as of the 12 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gothenburg), 16 studies
PhaseStudiesRecruitingShare
Phase 39356.3%
Phase 24225%
Phase 1/23318.8%

Most active sponsors

Lead sponsors with the most studies (Gothenburg)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC168
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.